TITLE

Autologous recovery following non-myeloablative unrelated donor bone marrow transplantation for severe aplastic anaemia

AUTHOR(S)
Elebute, M.; Ball, S.; Gordon-Smith, E.; Sage, D.; Marsh, J.
PUB. DATE
July 2002
SOURCE
Annals of Hematology;Jun2002, Vol. 81 Issue 7, p378
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
We report the outcome of nine unrelated bone marrow transplants performed for acquired severe aplastic anaemia at a single centre. Six patients received transplants from fully matched donors. Three donor/recipient pairs were mismatched, two at a single allele on high resolution typing. Pre-transplant conditioning consisted of cyclophosphamide and in vivo Campath-1 monoclonal antibody. One patient also received total body irradiation (TBI), and another patient with a coexisting paroxysmal nocturnal haemoglobinuria (PNH) clone received additional busulphan. Cyclosporin A was given for 12 months as prophylaxis against graft-versus-host disease (GVHD). Six of nine patients are alive and transfusion independent with a mean follow-up of 24 months (range: 1.5–94). All six patients who received fully matched transplants are alive; the three who received mismatched grafts died. Four long-term survivors developed autologous haematological recovery following rejection of their grafts. Acute GVHD grade II+ occurred in two patients. We highlight the importance of high-resolution HLA typing, including Cw matching in reducing the incidence of graft rejection and GVHD, resulting in improved survival in our patient group. This study also shows that autologous recovery with long-term survival can occur following non-irradiation conditioning regimens.
ACCESSION #
15684944

 

Related Articles

  • haematology. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p354 

    An encyclopedia entry for "haematology" is presented. It refers to the study of blood and its formation, which also deals with the investigation and treatment of blood and bone marrow disorders. Blood disorders, such as anemia and leukemia, are diagnosed via microscopic examination and counting...

  • Interleukin-23 receptor (IL-23R) gene polymorphisms in acquired aplastic anemia. Takaku, Tomoiku; Calado, Rodrigo T.; Kajigaya, Sachiko; Young, Neal S. // Annals of Hematology;Jul2009, Vol. 88 Issue 7, p653 

    Acquired aplastic anemia (AA) is a rare disease with a complex pathogenesis. In most cases, T cell-mediated immune destruction of hematopoietic cells results in peripheral blood pancytopenia and bone marrow hypoplasia. A subset of the heterodimeric interleukin-23 receptor gene (IL-23R) is...

  • Preserved levels of uninvolved immunoglobulins are independently associated with favorable outcome in patients with symptomatic multiple myeloma. Kastritis, E; Zagouri, F; Symeonidis, A; Roussou, M; Sioni, A; Pouli, A; Delimpasi, S; Katodritou, E; Michalis, E; Michael, M; Hatzimichael, E; Vassou, A; Repousis, P; Christophoridou, A; Kartasis, Z; Stefanoudaki, E; Megalakaki, C; Giannouli, S; Kyrtsonis, M-C; Konstantopoulos, K // Leukemia (08876924);Oct2014, Vol. 28 Issue 10, p2075 

    Suppression of uninvolved immunoglobulins is common in multiple myeloma (MM) but the prognostic significance of this phenomenon has not been assessed. We evaluated the prognostic significance of the preservation of uninvolved immunoglobulins in 1755 consecutive, unselected, patients with newly...

  • Introduction. Keohane, Elaine M. // Clinical Laboratory Science;Summer2004, Vol. 17 Issue 3, p164 

    Introduces several articles on anemia associated with bone marrow failure.

  • Hematological features of pediatric systemic lupus erythematosus: suggesting management strategies in children. Gokce, M; Bilginer, Y; Besbas, N; Ozaltın, F; Cetin, M; Gumruk, F; Ozen, S // Lupus;Aug2012, Vol. 21 Issue 9, p878 

    Aim: The aim of this study was to analyze the hematological features in children with systemic lupus erythematosus (SLE) and to review our current treatment protocols. Methods: We evaluated hematological findings of 43 children with SLE diagnosed and followed at the Pediatric Rheumatology...

  • Biosimilar recombinant human erythropoietin induces the production of neutralizing antibodies. Praditpornsilpa, Kearkiat; Tiranathanagul, Khajohn; Kupatawintu, Pawinee; Jootar, Saengsuree; Intragumtornchai, Tanin; Tungsanga, Kriang; Teerapornlertratt, Tanyarat; Lumlertkul, Dusit; Townamchai, Natavudh; Susantitaphong, Paweena; Katavetin, Pisut; Kanjanabuch, Talerngsak; Avihingsanon, Yingyos; Eiam-Ong, Somchai // Kidney International;Jul2011, Vol. 80 Issue 1, p88 

    Recombinant human erythropoietin (r-HuEpo) has been used for the treatment of renal anemia. With the loss of its patent protection, there has been an upsurge of more affordable biosimilar agents, increasing patient access to treatment for these conditions. The complexity of the manufacturing...

  • Chapter 6: The Macrocytic Anemias. Ciesla, Betty // Hematology in Practice;2007, p85 

    Chapter 6 of the book "Hematology in Practice" is presented. It defines megaloblastic anemia as a macrocytic anemia. The morphological characteristics of megaloblasts and normoblasts in the bone marrow are compared and contrasted. it also describes the ineffective hematopoiesis as it related to...

  • Prognosis of patients with del(5q) MDS and complex karyotype and the possible role of lenalidomide in this patient subgroup. Giagounidis, A. A. N.; Germing, U.; Strupp, C.; Hildebrandt, B.; Heinsch, M.; Aul, C. // Annals of Hematology;Sep2005, Vol. 84 Issue 9, p569 

    The survival of patients with myelodysplastic syndromes is strongly affected by chromosomal abnormalities. Patients with an isolated del(5q31) have a favourable prognosis that worsens with the addition of another chromosomal abnormality. It has been reported that both patients with isolated...

  • Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia Following Apparent Acute Lymphoblastic Leukemia. Hajjar, Katherine A. // Clinical Pediatrics;Jul1985, Vol. 24 Issue 7, p402 

    The observation that Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL) may progress lo chronic myelogenous leukemia (CML) has been well-documented among adult patients but reported only rarely in children. In this report, we describe a pediatric patient with atypical ALL, who...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics